10/04/2024
“Getting FDA approval for a specific indication takes a lot of money. Naltrexone, which was FDA-approved at high doses for prevention of narcotic and alcohol abuse in 1984, has a high bar to jump over,” said Weinstock. “It is hard to do expensive studies on a generic drug.”
Some research supports the use of anti-inflammatory low-dose naltrexone for chronic pain and autoimmune conditions.
